Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / House Bills / H.R. 4472

H.R. 4472

To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.

Print stageDateSize⠃
Introduced in House2021-07-161.4K⠃⠗⠋